Humana Inc. HUM
Regular-session close
After hours · Nov 20, 7:54 PM ET
- YTD
- +52.27%
- 1 year
- +74.66%
5D -67.21 (-14.70%)
- Market cap
- 46.84B
- Revenue (ttm)
- 154.19B
- Profit margin
- 0.81%
- EPS (ttm)
- 10.25
- Shares out
- 120.10M
- P/E ratio
- 38.05
- Forward P/E
- 21.13
- Dividend
- 3.54 (0.93%)
- Ex-dividend date
- Dec 24, 2026
- YTD return
- +52.27%
- 1-year return
- +74.66%
- Volume
- 2.32M
- Avg volume
- 1.44M
- Open
- 392.54
- Previous close
- 380.00
- Day's range
- 387.83 – 401.87
- 52-week range
- 163.67 – 461.25
- Beta
- 0.64
- Analysts
- Buy
- Price target
- 508.54 (+30.4%)
- Earnings date
- Feb 10, 2027
- 50-day average
- 409.98
Key statistics
- 200-day average
- 321.86
- Enterprise value
- 33.97B
- PEG ratio
- 1.13
- Price / sales
- 0.30
- Price / book
- 2.49
- Payout ratio
- 34.54%
- Revenue growth
- 26.10%
- Free cash flow
- 3.29B
- Total cash
- 25.11B
- Total debt
- 13.37B
- Return on equity
- 6.74%
- Short % of float
- 2.63%
Fundamental scorecard
18 of 25 checks passed on HUM’s reported financials
18of 25 checks passed
- Value 3 of 5
- Growth 3 of 5
- Profitability 3 of 5
- Financial health 5 of 5
- Dividend 4 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: buy
- Target (low)
- 280.00
- Target (mean)
- 508.54
- Target (high)
- 602.00
- Strong buy5
- Buy13
- Hold7
- Sell1
- Strong sell0
Next earnings
Feb 10, 2027
Expected Feb 10, 2027. Consensus EPS estimate -7.58.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 10, 2027 | Dec 30, 2026 | -7.54 | — | — | — |
| Nov 6, 2026 | Sep 30, 2026 | -1.00 | -0.70 | +0.30 | +30.00% |
| Jul 29, 2026 | Jun 30, 2026 | 7.27 | 7.61 | +0.34 | +4.68% |
| Apr 29, 2026 | Mar 31, 2026 | 10.24 | 10.31 | +0.07 | +0.68% |
| Feb 11, 2026 | Dec 31, 2025 | -4.00 | -3.96 | +0.04 | +1.00% |
| Nov 5, 2025 | Sep 30, 2025 | 2.93 | 3.24 | +0.31 | +10.58% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 20, 2026 | TD Cowen | up | Hold | Buy |
| Nov 19, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Nov 12, 2026 | Wells Fargo | main | Overweight | Overweight |
| Nov 11, 2026 | TD Cowen | main | Hold | Hold |
| Nov 10, 2026 | JP Morgan | main | Neutral | Neutral |
| Nov 9, 2026 | Piper Sandler | main | Overweight | Overweight |
About Humana Inc.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- humana.com
News
Bull of the Day: Humana (HUM)
Humana Is Up More Than 50% This Year, but $1,000 From Three Years Ago Is Still Worth Less Than $1,000
Nasdaq 100 Tumbles Over 3% Amid Tech Bloodbath, Nvidia Sinks 7% on 7th Straight Weekly Loss: Stock Market Today
Should Value Investors Buy Humana (HUM) Stock? TD Cowen Upgrades Humana to Buy, Raises Price Target to $485
Two 68-Year-Old Neighbors With Diabetes Leave Medicare Advantage by Dec. 7. His Plan Is Closing, So Medigap Must Take Him. She’s Leaving by Choice, So a Medigap Insurer Can Turn Her Down
Humana: The Proposed CRUSH Rule Creates A Buying Opportunity
Humana Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Humana (HUM)
UnitedHealth Stock Slips: What's Going On? Morgan Stanley Maintains Equal-Weight on Humana, Raises Price Target to $475
Your note
Sign in to keep a note on HUM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN CELESTE M | Chief Financial Officer | Stock Award(Grant) | Feb 12, 2025 | 23,291 |
| DIAMOND SUSAN M | Chief Financial Officer | Conversion of Exercise of derivative security | Dec 12, 2024 | 22,378 |
| DINTENFASS DAVID | Officer | Stock Award(Grant) | Apr 30, 2026 | 25,407 |
| MARTIN AARON | Officer | Stock Award(Grant) | Apr 30, 2026 | 25,237 |
| MEHTA JAPAN | Chief Technology Officer | Stock Award(Grant) | Apr 30, 2026 | 17,176 |
| MELLET CELESTE | Chief Financial Officer | Stock Award(Grant) | Apr 30, 2026 | 39,637 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.98% | 10,782,712 | 4.20B | Sep 29, 2026 |
| Dodge & Cox Inc. | 8.52% | 10,233,109 | 3.99B | Sep 29, 2026 |
| Vanguard Capital Management LLC | 6.55% | 7,860,914 | 3.07B | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 4.83% | 5,803,599 | 2.26B | Sep 29, 2026 |
| State Street Corporation | 4.62% | 5,543,942 | 2.16B | Sep 29, 2026 |
| JPMORGAN CHASE & CO | 3.31% | 3,981,196 | 1.55B | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 6.12% | 7,354,500 | 2.87B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 3,811,711 | 1.49B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 3,111,659 | 1.21B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.17% | 2,601,473 | 1.01B | Jun 29, 2026 |
| AMERICAN FUNDS FUNDAMENTAL INVESTORS | 1.41% | 1,690,812 | 659.26M | Sep 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 1,600,377 | 624.00M | Sep 29, 2026 |
